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In various types of snake venom, the major toxic components are proteinases and mem-
bers of the phospholipase A2 family, although other enzymes also contribute to the
toxicity. In this study, we evaluated the proteolytic, phospholipase, and L-Amino acid ox-
idase activities in the venom of ﬁve Bothrops speciesdBothrops jararaca, Bothrops jarar-
acussu, Bothrops moojeni, Bothrops neuwiedi, and Bothrops alternatusdall of which are used
in the production of commercial antivenom, prepared in horses. The enzymatic activities
of each species’ venom were classiﬁed as high, moderate, or low. B. moojeni venom
demonstrated the highest enzymatic activity proﬁle, followed by the venom of B. neuwiedi,
B. jararacussu, B. jararaca, and B. alternatus. To our knowledge, this is the ﬁrst study to
compare all of these enzymes from multiple species, which is signiﬁcant in view of the
activity of L-amino acid oxidase across Bothrops species.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
In Brazil, snakes of the genusBothrops are responsible for
more than 70% of all reported snake bites (Bochner and
Struchiner, 2003; Saúde, 2010). There are approximately
thirty species in this genus, phylogenetically distributed
across seven groups named after the representative species
Bothrops alternatus; Bothrops atrox; Bothrops jararaca;
Bothrops jararacussu; B.microphthalmus; Bothrops neuwiedi;
and B. taeniatus. However, some researchers consider the
groups B. microphtalmus and B. taeniatus to be members of
the Bothrocophias and Bothriopsis genera, respectively
(Campbell and Lamar, 2004; Gutberlet and Campbell, 2001).
The species Bothrops moojeni belongs to the B. atrox group,þ55 16 3602 3315.
sa).
. All rights reserved.together with the species Bothrops asper; Bothrops leucurus
and Bothrops marajoensis (Furtado et al., 2010).
Various components have been isolated from Bothrops
venom, including enzymes such as serine proteinases,
metalloproteinases, phospholipases A2 (PLA2), L-amino
acid oxidases (LAAO), nucleotidases, and hyaluronidases;
and proteins with other activities, such as disintegrins,
members of the C-type lectin family, and others (Braud
et al., 2000; Chaves et al., 1995; Kini, 2006; Nunes et al.,
2011; Sant’Ana et al., 2011; Toyama et al., 2011).
Serine proteinases contain a reactive serine residue at
the active site, which is stabilized by the presence of his-
tidine and aspartic acid residues (Serrano and Maroun,
2005). Although homogenous in their structural charac-
teristics, snake venom serine proteinases can present
highly diverse pharmacological proﬁles, acting on various
components of the coagulation cascade and the ﬁbrinolytic
and kallikrein-kinin systems (Serrano and Maroun, 2005;
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be glycoproteins with the number and position of N- or O-
glycosylation sites differing from one enzyme to another
(Serrano and Maroun, 2005).
Metalloproteinases are enzymes that depend on metal
ions to be active. Snake venom metalloproteinases are
associatedwithhemorrhage,myonecrosis, skindamage, and
reactions manifesting as inﬂammation or edema (Gomes
et al., 2011; Gutierrez et al., 2009; Teixeira et al., 2005).
Members of the PLA2 family are calcium-dependent
enzymes that catalyze the hydrolysis of the sn-2 ester
bond of phosphoglycerides, leading to the formation of free
fatty acids and lysophospholipids (da Silva Cunha et al.,
2011; Fuly et al., 2000). In many types of snake venom,
the majority of the toxic components are composed of PLA2
isoforms. In addition to their role in prey digestion, they
impair certain major physiological functions and can cause
presynaptic neurotoxicity and myotoxicity, as well as
inhibit coagulation and platelet aggregation. They are also
involved in the development of convulsions, inﬂammation,
hypotension, hemolysis, and hemorrhage, potentially
contributing to the development of edema (Campos et al.,
2009; Fortes-Dias et al., 1999; Fuly et al., 2007; Huang
et al., 1997; Leiguez et al.; Moreira et al.).
In the venom of various snakes, members of the LAAO
family also contribute to toxicity. The LAAOs catalyze the
oxidative deamination of speciﬁc L-amino acids to produce
the corresponding alpha-keto acid, hydrogen peroxide, and
ammonia. An LAAO typically presents as a homodimeric
acidic glycoprotein with a ﬂavin cofactor. Studies have
shown that snake venom LAAOs are involved in the
apoptosis of various cell lines, such as vascular endothelial
cells, which could contribute to prolonged bleeding after a
snake bite (Alves et al., 2008; Suhr and Kim, 1996). In
addition, LAAOs can inhibit platelet aggregation, thereby
having an anticoagulant effect (Sakurai et al., 2003).
Bothrops envenomation is characterized by cardiovas-
cular effects, proteolytic activity with a pronounced local
effect, myonecrosis, hemorrhage, and edema, all of which
are attributable to the synergism of these enzymes,
together with the effects of other components (Gutierrez
et al., 2009; Machado et al., 2010; Mebs and Ownby, 1990).
In Brazil, Bothrops antivenom is currently produced at
the Butantan Institute in Sao Paulo. The antivenom is pre-
pared by hyper-immunizing healthy horses using the
venom of ﬁve species: B. jararaca; B. jararacussu; B. alter-
natus; B. moojeni; and B. neuwiedi (Furtado et al., 2010).
Multiple species are used because there are differences
among the species regarding the components of the venom
(Furtado et al., 2010; Neiva et al., 2009; Nunez et al., 2009).
The goal of the present study is to demonstrate the quali-
tative and quantitative differences among these species in
terms of the complexity and diversity of proteinases, PLA2s,
and LAAOs found in the venom of these ﬁve species.
2. Materials and methods
2.1. Biological and chemical reagents
Aliquots of B. jararaca, B. jararacussu, B. moojeni, B.
neuwiedi, and B. alternatus venom were obtained from theSerpentarium at the Faculty of Medicine of Ribeirão Preto,
University of São Paulo (Faculdade de Medicina de Ribeirão
Preto, Universidade de São Paulo), Brazil. For each species,
venom was extracted from three snakes captured in
different regions of São Paulo state and pooled. The venom
aliquots were stored at 20 C until analysis. Protein con-
tent was measured by the Lowry method, modiﬁed by
Hartree (1972), using bovine serum albumin as the stan-
dard. Sheep erythrocytes (Newprov, Pinhais, Brazil) were
collected in heparinized tubes (Becton Dickinson, Franklin
Lakes, NJ, USA), centrifuged for 20 min at 300  g at 4 C,
washed 3 times with PBS, pH 7.4, and centrifuged again.
Chemicals and reagents were purchased from Sigma
(Sigma Chemical Co., St. Louis, MO, USA).
2.2. Hemolytic activity
A modiﬁed kinetic indirect hemolytic assay, standard-
ized in our laboratory (Tamarozzi et al., 2006), was per-
formed to measure PLA2 activity. We used egg yolk as a
substrate to develop a turbidimetric assay based on the
capacity of snake venom PLA2s to hydrolyze egg phospha-
tidylcholine, producing lysophosphatidylcholine and fatty
acids. The lysophosphatidylcholine accumulates on eryth-
rocyte membranes, promoting their disruption and initi-
ating the hemolysis process (Bierbaum et al., 1979). This
assay was conducted in triplicate in a 96-well microplate
(Costar, Corning Incorporated, NY, USA) and samples were
analyzed at 650 nm, considering that this is well outside of
the hemoglobin absorption wavelength and that the
absorbance is proportional to the cell concentration.
The hemolysis solution consisted of 10 ml of Tris–HCl
buffer, pH 7.4, containing 140mMNaCl, 2.5 mM CaCl2, 25 ml
of egg yolk diluted 1:4 (v/v) in sterile saline solution (NaCl
0.9%), and 1.5 ml of erythrocytes. The reaction mixture was
prepared by adding 175 ml of hemolysis solution and 75 ml
of venom samples (20 mg/ml). The microplate was incu-
bated at 37 C and the decrease in absorbancewas recorded
at intervals of 5,10, and 15min. A saline solution containing
no venom was used as a negative control. The blank solu-
tion was prepared by adding venom to the hemolysis so-
lution to achieve a ﬁnal concentration of 80 mg/ml. After 1 h
of incubation at 37 C, this solution was used to calibrate
the microplate reader (Molecular Devices, Sunnyvale, CA,
USA). Statistical analyses were based on the absorbance
after 90 min of reaction.
2.3. Proteolytic activity
Proteolytic activity was assayed by a modiﬁed casein-
olytic method (Sanchez et al., 1992). The reaction mixture
consisted of venom (50 and 100 mg/ml) diluted in 500 ml of
50 mM Tris–HCl, pH 7.4, 2.0 mM CaCl2, and 0.5% (w/v)
denatured casein. After 3 h of incubation at 37 C, the re-
action was terminated by adding 500 ml of 10% (w/v) tri-
chloroacetic acid (TCA). Non-digested proteins were
removed by centrifugation at 11,600  g for 5 min, and the
peptide content in the clear supernatant was measured at
280 nm with a spectrophotometer (DU 640; Beckman
Coulter, Palo Alto, CA, USA). As a negative control, we used
water instead of venom. To determine whether the protein
L.B. Campos et al. / Toxicon 76 (2013) 1–10 3contents of the venom samples contributed to increases in
absorbance, we prepared a control with each venom sam-
ple previously denatured with TCA before the addition of
the substrate solution. As expected, the results were similar
to those obtained with the negative control (data not
shown).
2.4. LAAO activity
LAAO activity was measured by a colorimetric method
adapted from Costa Torres et al. (2010). The method was
based on the oxidative deamination of the substrate (L-
leucine), generating hydrogen peroxide. Adding horse-
radish peroxidase (HRP) to the reaction media reduces the
hydrogen peroxide in the presence of o-phenylenediamine
(OPD) to form a yellowish product, which can be measured
spectrophotometrically. Reactions were conducted in trip-
licate in a 96-well microplate. Two different concentrations
(5.0 and 10.0 mg/ml) of each venomwere incubated for 1 h
at 37 C, in 150 ml of 100 mM Tris–HCl, pH 7.4, containing
2.0 mM L-leucine, 0.8 U/ml HRP (horseradish peroxidase),
and OPD (o-Phenylenediamine dihydrochloride), diluted as
indicated by the manufacturer Sigma. The reaction was
stopped by adding 75 ml of 2.0 M sulfuric acid and the
absorbance was measured at 490 nm using a microplate
reader. As a negative control (and blank), we used water
instead of venom. As a positive control, we used hydrogen
peroxide diluted 1:6000.
2.5. Protein analysis and molecular weight assays
2.5.1. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis
Venom samples were compared by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a
12% polyacrylamide gel under non-reducing conditions
with silver staining, as described by Sambrook (Sambrook
and Russell, 2001).
2.5.2. Zymography of PLA2s
In order to identify and estimate the molecular weights
of PLA2s, we analyzed the venom samples using zymog-
raphy, incorporating modiﬁcations described previously
(Rossignol et al., 2008). Samples of venom (2.5 mg each)
were electrophoresed at 60 V and 4 C on a 12% poly-
acrylamide gel under non-reducing conditions. The gel was
washed for 1 h in 500mM Tris–HCl, pH 7.4, containing 2.0%
(v/v) Triton X-100 and for another 1 h in 100 mM Tris–HCl,
pH 7.4, containing 1.0% (v/v) Triton X-100. After SDS resi-
dues had been removed, the gel was washed a third time
for 30 min in 50 mM Tris–HCl, pH 7.4, containing 140 mM
NaCl and 2.5 mM CaCl2. It was then incubated for 14 h at
room temperature over a 1.0% (w/v) agarose gel prepared in
50 mM Tris–HCl, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2, and
2.0% egg yolk. Clear zones indicated the presence of PLA2.
2.5.3. Zymography of proteinases
We identiﬁed proteinases using a modiﬁed form of the
zymography technique described previously (Heussen and
Dowdle, 1980), as cited by Zelanis et al. (2007). Samples of
each venom (40 mg each) were applied to a 12%polyacrylamide gel, which was copolymerized with 0.07%
(w/v) denatured casein. Samples were prepared in the
presence of SDS and in the absence of reducing agents, after
which they were electrophoresed at 60 V and 4 C. After
electrophoresis, the gel was washed for 30 min in 50 mM
Tris–HCl, pH 7.4, containing 2.0% (w/v) Triton X-100, at
room temperature. Next, the buffer was replaced and the
gel was washed again. After removal of all residues of SDS,
the gel was incubated for 16 h in 50 mM Tris–HCl, pH 7.4,
containing 150 mM NaCl and 2.5 mM CaCl2, at 37 C. It was
then stained with 0.5% Coomassie Brilliant Blue R-250 in
40% (v/v) methanol and 10% (v/v) acetic acid for 1 h.
Destaining was performed in 40% (v/v) methanol and 10%
(v/v) acetic acid. Venom proteinases hydrolyzed the casein
dissolved in the gel, presenting clear zones against the blue
background.
2.5.4. Zymography of LAAOs
The molecular weights of LAAOs were estimated by
zymography, as described by Campos et al. (2012). Brieﬂy,
40 mg of each venom sample was electrophoresed under
non-reducing conditions and the gel was treated with
150mM Tris–HCl, pH 7.2, supplemented with 1.0% Triton X-
100 for removing SDS residues. The gel was then overlaid
on another gel prepared in 150 mM Tris–HCl buffer, pH 7.4,
supplemented with 1.0% agarose, 0.8 U/mL HRP, 2.5 mM L-
leucine, and OPD diluted as indicated by the manufacturer.
The presence of the enzymes was conﬁrmed by the
appearance of yellowish bands.
2.6. Enzymatic activity classiﬁcation
For elucidating the activity of venom enzymes (PLA2,
proteinases, and LAAO), we sorted enzymatic activities in
Bothrops venom into different levels, namely, low, moder-
ate and high. The classiﬁcation was performed using the
results of the hemolytic, proteolytic and LAAO activity as-
says. The results of the zymograms were excluded, since
they do not necessarily reﬂect the activity of all proteins.
This classiﬁcation is restricted to venom from the species
included in this study and the speciﬁc methods used.
2.7. Statistical analysis
Results are indicated as means and standard deviations.
Data were submitted to analysis of variance followed by




In order to compare the Bothrops venoms, in terms of
their biological activity, we tested the PLA2, proteinase, and
LAAO groups of enzymes.
All venoms demonstrated PLA2 activity, as evidenced by
their hemolytic effects (Fig. 1). Although B. moojeni venom
displayed amore rapid decrease in absorbance, followed by
the venoms of B. neuwiedi and B. jararacussu, these three
venoms showed no signiﬁcant differences after 90 min of
Fig. 1. Phospholipase A2 activity. Venoms were incubated with the hemo-
lysis solution (250 ml) to a ﬁnal concentration of 20.0 mg/ml for 90 min at
37 C, and the decrease in absorbance was measured at the intervals of 5, 10,
or 15 min at 650 nm. The negative control was prepared by replacing the
venom with saline solution (NaCl 0.9%). To calibrate the plate reader, a re-
action mixture, previously incubated with 80 mg/ml of venom for 1 h at
37 C, was used. Statistical analysis was set considering the absorbance after
90 min of reaction. Data were collected in triplicate and submitted to
analysis of variance followed by Tukey’s post hoc test. Values of p < 0.05
were considered statistically signiﬁcant. Different letters indicate statistical
difference.
Fig. 3. L-amino acid oxidase activity. Different concentrations (5.0 and
10.0 mg/ml) of each venom were incubated in the presence of L-leucine, o-
phenylenediamine, horseradish peroxidase, and Tris–HCl pH 7.4 buffer for
1 h at 37 C. The reaction was stopped with H2SO4, and absorbance was
measured at 490 nm. As a negative control (also used as a blank), we used
water instead of venom, and, as a positive control, we used H2O2 diluted
1:6000. Results are expressed as means and standard deviations. Data were
collected in triplicate and submitted to analysis of variance followed by
Tukey’s post hoc test. Values of p < 0.05 were considered statistically sig-
niﬁcant. Different letters indicate statistical difference.
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signiﬁcantly lower PLA2 activity while the venom of B.
jararaca displayed an intermediate activity level.
Bothrops venoms also demonstrated proteinase activity
but with signiﬁcant quantitative differences (Fig. 2). B.
moojeni venom showed signiﬁcantly higher proteinase ac-
tivity, followed by B. neuwiedi venom. B. jararaca, B. jarar-
acussu, and B. alternatus venoms showed signiﬁcantly
lower proteinase activity (Fig. 8).
Signiﬁcant LAAO activity was also observed in all the
tested venoms (Fig. 3). The venom of B. neuwiedi and B.
moojeni showed signiﬁcantly higher LAAO activities,Fig. 2. Proteinase activity. Different concentrations (50.0 and 100.0 mg/ml) of
each venom were incubated in the presence of casein and Tris–HCl buffer,
pH 7.4, for 3 h at 37 C. The reaction was stopped with 10% trichloroacetic
acid, and non-digested proteins were removed by centrifugation at
11,600  g for 5 min. The peptide content of the supernatant was measured
at 280 nm. The negative control (also used as a blank) was prepared by
replacing the venom with water. Results are expressed as means and stan-
dard deviations. Data were collected in triplicate and submitted to analysis
of variance followed by Tukey’s post hoc test. Values of p < 0.05 were
considered statistically signiﬁcant. Different letters indicate statistical
difference.followed by that of B. jararaca and B. jararacussu. B. alter-
natus venom showed signiﬁcantly lower LAAO activity.
3.2. SDS-PAGE and zymography
In order to compare the various Bothrops venoms, in
terms of their protein proﬁles, the venoms were submitted
to electrophoresis under non-reducing conditions. The re-
sults of the SDS-PAGE analysis are shown in Fig. 4. DespiteFig. 4. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The
protein proﬁle of each venom (1.0 mg/lane) were analyzed on a silver-stained
12.0% polyacrylamide gel. 1, B. jararaca; 2, B. jararacussu; 3, B. moojeni; 4, B.
neuwiedi; 5, B. alternatus and M, protein ladder.
Fig. 5. Phospholipase A2 zymogram. [A] Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. [B] 1.0% agarose gel containing 2.0%
egg yolk after overnight incubation on a 12.0% polyacrylamide gel electro-
phoresis containing 2.5 mg of each venom per lane. M, molecular marker; 1,
B. jararaca; 2, B. jararacussu; 3, B. moojeni; 4, B. neuwiedi and 5, B. alternatus.
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their overall proﬁles showed substantial differences, except
in the case of B. moojeni versus B. neuwiedi.
The presence of PLA2 in the venoms was analyzed by an
egg yolk zymogram. All venoms displayed a clear zone at
approximately 15 kDa, which corresponds to PLA2 activity
against lecithin on the gel (Fig. 5). Although equal amounts
of venomwere used, different patterns of clear zones were
observed. This observation can be explained by differences
in the activity level of each enzyme and its concentration in
the venom. These ﬁndings are in accordance with the re-
sults obtained in the hemolytic assay.Fig. 6. Proteinase zymogram. Caseinolytic activity of proteinases (40.0 mg/
lane) on a 12.0% polyacrylamide gel copolymerized with 0.07% casein. M,
molecular marker; 1, B. jararaca; 2, B. jararacussu; 3, B. moojeni; 4, B. neu-
wiedi and 5, B. alternatus.The presence of proteinases in the venoms was
conﬁrmed by the appearance of clear zones against the
blue background on the casein zymogram (Fig. 6). B. jar-
araca venom showed intense casein degradation in the 25–
28 kDa range, while B. neuwiedi venom showed intense
degradation at 28 to 30 kDA. The venoms of B. jararacussu
and B. moojeni showed a lower degradation proﬁle at
approximately 30 kDa, while no clear zone was observed
for B. alternatus venom. Although all of the venoms showed
proteinase activity, as indicated in Fig. 2, only the venoms of
B. jararacussu and B. moojeni were similar in their patterns
of casein degradation.
The venoms also showed LAAO activity, as conﬁrmed by
the presence of yellowish bands in the OPD zymogram
(Fig. 7), nevertheless, their molecular mass was variable. B.
jararaca venom showed the most intense yellowish band,
around 97 kDa. While B. jararacussu and B. moojeni venoms
showed similar band proﬁles at approximately 84 and
82 kDa, respectively. B. neuwiedi venomwas unique in that
it displayed two yellow bands. One intense band of 75 kDa
and another, less intense band of 119 kDa were detected. B.
alternatus venom displayed the enzyme at approximately
107 kDa.4. Discussion
Proteinases and PLA2s are considered the major toxic
compounds in almost all snake venoms, although other
enzymes also contribute to the toxicity (Correa-Netto et al.,Fig. 7. L-amino acid oxidase zymogram. A sodium dodecyl sulfate-
polyacrylamide gel electrophoresis containing each venom (40 mg/lane)
was laid over another gel supplemented with 1.0% agarose, 0.8 U/mL HRP,
2.5 mM L-leucine, and OPD. The LAAOs activity was observed by the
appearance of yellowish bands. M, molecular marker; 1, B. jararaca; 2, B.
jararacussu; 3, B. moojeni; 4, B. neuwiedi and 5, B. alternatus.
Fig. 8. Overall relative comparison of venoms regarding their enzymatic
activities, which were classiﬁed as low (white), moderate (gray), or high
(black).
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enzyme present in the venom of pit vipers, however, it
accounts for about 0.5% of the total toxin transcripts from
the venom glands, a small percentagewhen comparedwith
the 53.1% and 28.5% reported for metalloproteinases and
serine proteinases, respectively (Cidade et al., 2006).
In the present study, we evaluated the PLA2, proteolytic,
and LAAO activities of the venoms of ﬁve different Bothrops
species: B. jararaca, B. jararacussu, B. moojeni, B. neuwiedi,
and B. alternatus. Such enzymatic variations are highly
relevant, given that the venom of these species is used in
the production of bothropic antivenom in Brazil (Furtado
et al., 2010). It is noteworthy that, with the exception of
B. neuwiedi, all of the snakes evaluated are on the list of
venomous snakes of highest medical signiﬁcance in the
Americas (World Health Organization, 2010).
In the southeast of Brazil, B. jararaca is the most com-
mon snake species and it is responsible for most of the
snake bites in the region, although it is not responsible for
the most severe cases of envenomation (Cruz et al., 2009).
With regards to PLA2, it comprises a small percentage of the
venom (0.7%), which may explain the relatively low degree
of myonecrosis in victims compared to other Bothrops
species (Cidade et al., 2006). In agreement with this, our
results showed that B. jararaca presents moderate PLA2
activity, as previously described (Serrano et al., 1999). The
venom also displayed moderate proteolytic activity. B. jar-
araca venom contains several well-described proteinases,
such as jararagin (a 52 kDa hemorrhagic metal-
loproteinase), two ﬁbrinolytic metalloproteinases (21 and
47 kDa, respectively), a 67-kDa trypsin-like serine pro-
teinase, small hemorrhagins (w25 kDa), and others
(Maruyama et al., 1992; Murayama et al., 2003; Paine et al.,
1992). In our zymography analysis, we found that B. jar-
araca venom effected intense casein hydrolysis with bands
ranging in size from 25 to 28 kDa. Two other disconnected
clear zones were also visible, one atw24 kDa (intense) andthe other atw20 kDa (less intense). In relation to LAAO, B.
jararaca venom again displayed moderate enzyme activity.
A study comparing the microbicidal activity of several
venoms found that the venom of B. jararaca was the most
active and that this was related to its LAAO activity
(Ciscotto et al., 2009).
B. jararacussu is found in the southeastern region of
Brazil (FUNASA, 2001). Although the local effects of B. jar-
aracussu venom are similar to other Bothrops venoms, some
of the systemic effects resemble those of Crotalus spp. en-
venomation. This could explain the greater clinical effec-
tiveness of Crotalus antivenom over Bothrops antivenom in
cases of B. jararacussu snake bites (Milani Jr. et al., 1997). In
the present study, B. jararacussu venom showed high he-
molytic activity, which is likely attributable to the biolog-
ical activity of several PLA2 enzymes that have been
identiﬁed in the venom, such as SIIISPIIB (Ketelhut et al.,
2003), Bothropstoxin-I (Cintra et al., 1993), Bothropstoxin
II (Pereira et al., 1998) and Bj IV (Bonﬁm et al., 2001). The
PLA2 zymogram showed an intense band at around 15 kDa,
similar to the enzymes previously described (about 13–
15 kDa). However, B. jararacussu venom showed moderate
proteolytic activity. The zymogram revealed caseinolytic
activity at 28–30 kDa, which could be explained by the
activity of multiple proteinases, such as a 30 kDa P-I met-
alloproteinase (Correa-Netto et al., 2010) and a 28-kDa
serine proteinase (Bortoleto et al., 2002). The gel also
revealed proteolytic activity at w34 kDa and a slight clear
zone at 24 kDa, which could be explained by the presence
of a 34 kDa serine proteinase and a 24 kDa P-I metal-
loproteinase (Correa-Netto et al., 2010). However, other
known proteinases were not observed (Correa-Netto et al.,
2010). B. jararacussu venom also showed moderate LAAO
activity. Proteomic studies have revealed that B. jararacussu
venom contains LAAO isoforms, with molecular masses
ranging from 47 to 78 kDa (Correa-Netto et al., 2010), as can
be conﬁrmed by the LAAO zymogram results. Recently an
isoform of 65 kDa was puriﬁed and crystalized (Ullah et al.,
2012).
B. moojeni is commonly found in central and south-
eastern Brazil, being most proliﬁc in the savanna(‘Cerrado’)
(Borges and Araujo, 1998; FUNASA, 2001). Studies have
revealed that B. moojeni venom exhibits high proteolytic
activity and low hemorrhagic action, with high PLA2 levels
and coagulant properties (Assakura et al., 1985). In the
present study, B. moojeni venom showed the highest ac-
tivity among all the enzymes tested. The high PLA2 activity
might be explained by the presence of two acidic phos-
pholipases, the 19 kDa BM-PLA2 and the 15 kDa BmooTX-I
(Nonato et al., 2001; Santos-Filho et al., 2008). These data
are in accordance with those obtained in the PLA2 zymo-
gram. B. moojeni venom also showed high proteolytic ac-
tivity, although the zymogram did not indicate intense
casein hydrolysis. It has been reported that B. moojeni
venom contains multiple proteinases, including serine
proteinases and metalloproteinases, with molecular
masses ranging from 22 to 34 kDa (Assakura et al., 1985;
Bernardes et al., 2008; Serrano et al., 1993a). Those re-
ports are in accordance with our zymography ﬁndings
(proteinases ofw30 kDa). It has also been reported that B.
moojeni venom contains a metalloproteinase composed of
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et al., 1993b). However, we were unable to observe that
metalloproteinase in our zymogram, which may be due to
the fact that it does not renature correctly after the removal
of SDS residues. The high phospholipase and proteinase
activities of this venom might be responsible for the
severity of local damage, as well as for the deleterious ef-
fects that it has on renal epithelia in snake bite victims
(Assakura et al., 1985; Boer-Lima et al., 1999).We also found
high LAAO activity levels, however, the corresponding
yellowish band in our zymogram was smaller than the
130.8 kDa LAAO enzyme previously reported by other au-
thors (Stabeli et al., 2007). This LAAO has already been
described to have a potent killing effect in vitro against
Leishmania spp. (Tempone et al., 2001). The highest enzy-
matic activities of B. moojeni is reﬂected in other species
belonging to the B. atrox group, which is responsible for a
large proportion of the fatalities related to snake bites in
South and Central America (Gutierrez et al., 2006).
Unlike the other species evaluated in the present study,
B. neuwiedi is not on the World Health Organization list of
medically important venomous snakes in the Americas
(World Health Organization, 2010). The species is found
throughout southern, southeastern, central, and north-
eastern Brazil (FUNASA, 2001). In the present study, the B.
neuwiedi venom presented high PLA2 activity as well as the
most intense band in the zymography assay. In an earlier
study on B. neuwiedi venom, two PLA2 isoforms (15 and
16 kDa, respectively) were puriﬁed; these presented
marked edema-inducing activity (Daniele et al., 1995).
Another 15-kDa PLA2 isoform, with a different N-terminal
sequence, was also found to possess edema-inducing ac-
tivity (Daniele et al., 1997). On the other hand, B. neuwiedi
venom showed low proteinase activity in this study. The
zymogram showed intense caseinolytic activity over the
range of 26–28 kDa and a slight clear zone at 24 kDa. This
venom presents awell-described 22 kDametalloproteinase
called neuwiedase (Lopes et al., 2009; Rodrigues et al.,
2001); two other metalloproteinases, both of w24 kDa
and with similar electrophoretic proﬁles but different iso-
electric properties; and two additional metalloproteinases,
of 46- and 58-kDa, respectively, bothwith hemorrhagic and
caseinolytic properties (Mandelbaum et al., 1984). How-
ever, not all of these were observed in the zymogram. In
addition, B. neuwiedi venom showed high LAAO activity,
similar to that observed for B. moojeni venom. This activity
might be explained by the presence of a 65 kDa homodi-
meric protein capable of inducing platelet activation, as
well as having bactericidal, leishmanicidal, and antitumor
properties (Rodrigues et al., 2009).
The species B. alternatus is widely distributed
throughout southern and south-central Brazil, being pri-
marily responsible for cases of snake bites in those re-
gions (FUNASA, 2001). Our results demonstrated that B.
alternatus venom has low PLA2 activity. However, an acidic
PLA2 identiﬁed in B. alternatus venom was found to be the
major compound responsible for the lethality of this venom
in mice, producing cardiovascular alterations such as dys-
pnea, tachycardia, arrhythmia, and circulatory shock, as
well as tissue damage, including hemorrhage and necrosis
(Nisenbom et al., 1986a, 1986b). Nevertheless, it is knownthat the protein content of B. alternatus venom comprises
mostly metalloproteinases and serine proteinases, ac-
counting for 43.1% and 24.1%, respectively (Ohler et al.,
2010). The various metalloproteinases identiﬁed in B.
alternatus venom have molecular masses ranging from 22
to 100 kDa, and are capable of causing hemorrhage, edema,
myonecrosis, and coagulation disorders. The venom of B.
alternatus also contains many serine proteinases that pre-
sent coagulant and ﬁbrinogenolytic activities; these en-
zymes are considered less toxic than metalloproteinases
(Ohler et al., 2010). Although venomics studies have
revealed that metalloproteinases and serine proteinases
are considered the most toxic components (Cardoso et al.,
2010), we found that B. alternatus venom showed only
moderate proteolytic activity. Souza et al. (2000) found that
B. alternatus venom contains a 55 kDa metalloproteinase,
designated alternagin (Souza et al., 2000), which has been
shown to be the major component responsible for the
hemorrhagic effect of this venom, despite the fact that it
displayed low proteolytic activity on casein (Gay et al.,
2005). This could explain the moderate activity shown in
the liquid assay and the absence of activity on the zymo-
gram. B. alternatus showed the lowest LAAO activity. Ven-
omics studies have demonstrated that B. alternatus venom
contains ﬁve LAAO isoforms, with molecular masses
ranging from 50 to 57 kDa (monomeric form), collectively
accounting for 6.9% of the crude venom, and that there is a
high homology between these LAAOs and those found in B.
moojeni venom (Ohler et al., 2010). Nevertheless, in the
present study, the activity levels differed between those
two species, a fact that might be attributable to the use of
crude venom rather than puriﬁed enzymes. Despite the
relatively low overall enzymatic activity observed in our
study, B. alternatus bites have often been reported to cause
local tissue damage, hemorrhage, coagulation disorders,
respiratory failure, renal failure, and shock (Gay et al.,
2009).
On the basis of our results, we classiﬁed the enzymatic
activity in the venom of the ﬁve species evaluated as low,
moderate or high (Fig. 8). Other authors have reported that
venom components are not homogeneously distributed
among the various Bothrops species (Ferreira et al., 1992;
Francischetti et al., 1998; Hodgson and Wickramaratna,
2002; Leite et al., 1992; Moura-da-Silva et al., 1990;
Moura-da-Silva et al., 1991; Zamuner et al., 2004). However,
to our knowledge, this is the ﬁrst study to compare these
three enzyme classes. In particular, we found few studies
examining LAAO activity in Bothrops species.
5. Conclusion
We have demonstrated signiﬁcant variation among
Bothrops species in terms of the enzymes present in the
venom. According to our classiﬁcation, B. moojeni venom
showed the highest enzyme activity, followed by the
venoms of B. neuwiedi, B jararacussu, B. jararaca, and B.
alternatus. Knowledge of such differences is of great rele-
vance to the understanding of the effects of snake bite
envenomation, antiserum production, taxonomy, and
venom toxicity, as well as being essential to the study of
venom components as potential therapeutic targets.
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